Vivani Medical Inc (VANI)

$1.41 +0.01 (0.71%)
Market Cap 82.94M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 154,500
Avg Vol 155,844
Day's Range N/A - N/A
Shares Out 59.24M
Stochastic %K 13%
Beta 3.18
Analysts Strong Sell
Price Target $4.00

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
inelegantinvest
inelegantinvest Oct. 6 at 12:24 PM
$VANI delays Cortigent $CRGT spinoff after withdrawing the Oct 8 record date, citing U.S. gov’t shutdown. Rare record date reversal Both companies are micro-caps with limited cash High risk, high optionality Full breakdown: https://www.stockspinoffs.com/2025/10/06/vivani-cortigent-spinoff-delayed-vani-crg
0 · Reply
Manbearbulll
Manbearbulll Oct. 4 at 10:08 PM
$VANI i get the feeling they would have postponed the spin off regardless of a shutdown and the shutdown was just a convenient excuse. We were 5 days out and nobody had any details about it except 0ct 8th was the date.
1 · Reply
deedah
deedah Oct. 3 at 1:19 PM
$VANI has temporarily withdrawn the record date for ther spin-off of Cortigent "due to delays arising from the shutdown"
1 · Reply
wolfcyd3
wolfcyd3 Oct. 2 at 4:25 PM
$VANI
0 · Reply
ToniesPick
ToniesPick Oct. 2 at 2:45 PM
$VANI record date, updates and potential breakout next week, hopefully.
0 · Reply
BC322032
BC322032 Oct. 1 at 12:47 PM
$VANI
0 · Reply
signaljumper
signaljumper Sep. 29 at 8:55 PM
$VANI i think WE will get some News about the spin Off how many shares ww get from the spin Off.
0 · Reply
66Harry
66Harry Sep. 27 at 10:48 AM
$VANI The value will be licensing agreements by splitting two companies, there wear value comes in $$$$.
0 · Reply
inelegantinvest
inelegantinvest Sep. 26 at 6:55 PM
🚨 Spinoff update: DuPont $DD sets Oct 22 record date for Qnity Electronics $Q Vivani ($VANI) sets Oct 8 record date for Cortigent ($CRGT) Sony ($SONY) finalizes Oct 1 distribution for Sony Financial Details ➡️ https://www.stockspinoffs.com/2025/09/26/qnity-cortigent-sony-spinoff-record-dates/
0 · Reply
Joesh82
Joesh82 Sep. 25 at 6:51 PM
$VANI https://www.youtube.com/watch?v=WAGgrmlmKTs
0 · Reply
Latest News on VANI
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Oct 3, 2025, 8:30 AM EDT - 3 days ago

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Sep 24, 2025, 9:15 AM EDT - 12 days ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Sep 17, 2025, 8:30 AM EDT - 19 days ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Sep 4, 2025, 8:30 AM EDT - 4 weeks ago

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Aug 20, 2025, 8:30 AM EDT - 6 weeks ago

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:20 PM EDT - 7 weeks ago

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

I Missed The Quantum Rally - I Won't Miss The Next One

May 20, 2025, 5:47 AM EDT - 5 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR CLPT EDIT NTLA VERV

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 13, 2025, 4:30 PM EDT - 5 months ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

May 7, 2025, 8:30 AM EDT - 5 months ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Apr 15, 2025, 8:30 AM EDT - 6 months ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 7:30 AM EDT - 6 months ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 27, 2025, 7:32 AM EDT - 6 months ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 26, 2025, 7:30 AM EDT - 6 months ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 24, 2025, 8:30 AM EDT - 7 months ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 13, 2025, 7:30 AM EDT - 7 months ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Mar 12, 2025, 8:30 AM EDT - 7 months ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

Mar 12, 2025, 8:00 AM EDT - 7 months ago

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

CRGT

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 19, 2024, 8:30 AM EST - 10 months ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Dec 4, 2024, 8:30 AM EST - 10 months ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 8:30 AM EST - 11 months ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 23, 2024, 8:57 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 7:10 PM EDT - 1 year ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 28, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024, 4:45 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 6, 2024, 8:00 AM EST - 1 year ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Mar 1, 2024, 7:49 AM EST - 1 year ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 1 year ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Feb 28, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at BIO Investor Forum

Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Sep 5, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Aug 14, 2023, 5:45 PM EDT - 2 years ago

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Jun 14, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

May 15, 2023, 6:15 AM EDT - 2 years ago

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Apr 4, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 31, 2023, 2:50 PM EDT - 2 years ago

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Mar 21, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Nov 14, 2022, 4:46 PM EST - 3 years ago

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Vivani Medical to Present at the ThinkEquity Investor Conference

Oct 17, 2022, 6:00 AM EDT - 3 years ago

Vivani Medical to Present at the ThinkEquity Investor Conference

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Aug 31, 2022, 6:00 AM EDT - 3 years ago

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

inelegantinvest
inelegantinvest Oct. 6 at 12:24 PM
$VANI delays Cortigent $CRGT spinoff after withdrawing the Oct 8 record date, citing U.S. gov’t shutdown. Rare record date reversal Both companies are micro-caps with limited cash High risk, high optionality Full breakdown: https://www.stockspinoffs.com/2025/10/06/vivani-cortigent-spinoff-delayed-vani-crg
0 · Reply
Manbearbulll
Manbearbulll Oct. 4 at 10:08 PM
$VANI i get the feeling they would have postponed the spin off regardless of a shutdown and the shutdown was just a convenient excuse. We were 5 days out and nobody had any details about it except 0ct 8th was the date.
1 · Reply
deedah
deedah Oct. 3 at 1:19 PM
$VANI has temporarily withdrawn the record date for ther spin-off of Cortigent "due to delays arising from the shutdown"
1 · Reply
wolfcyd3
wolfcyd3 Oct. 2 at 4:25 PM
$VANI
0 · Reply
ToniesPick
ToniesPick Oct. 2 at 2:45 PM
$VANI record date, updates and potential breakout next week, hopefully.
0 · Reply
BC322032
BC322032 Oct. 1 at 12:47 PM
$VANI
0 · Reply
signaljumper
signaljumper Sep. 29 at 8:55 PM
$VANI i think WE will get some News about the spin Off how many shares ww get from the spin Off.
0 · Reply
66Harry
66Harry Sep. 27 at 10:48 AM
$VANI The value will be licensing agreements by splitting two companies, there wear value comes in $$$$.
0 · Reply
inelegantinvest
inelegantinvest Sep. 26 at 6:55 PM
🚨 Spinoff update: DuPont $DD sets Oct 22 record date for Qnity Electronics $Q Vivani ($VANI) sets Oct 8 record date for Cortigent ($CRGT) Sony ($SONY) finalizes Oct 1 distribution for Sony Financial Details ➡️ https://www.stockspinoffs.com/2025/09/26/qnity-cortigent-sony-spinoff-record-dates/
0 · Reply
Joesh82
Joesh82 Sep. 25 at 6:51 PM
$VANI https://www.youtube.com/watch?v=WAGgrmlmKTs
0 · Reply
AyeZeeLongHold
AyeZeeLongHold Sep. 25 at 4:09 AM
$VANI "About the Emerging Growth Conference" - though this line was interesting in regard to tomorrows meeting 👉 "...and other major announcements to the investment community..."
0 · Reply
AyeZeeLongHold
AyeZeeLongHold Sep. 25 at 3:38 AM
$VANI
0 · Reply
LongBallBarn
LongBallBarn Sep. 23 at 8:48 AM
$HOLO $ORIS $VANI $ARTL
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 23 at 8:29 AM
$VANI hot stocks
0 · Reply
Doozio
Doozio Sep. 22 at 11:36 PM
$VANI let’s bang bro! 🐒🍌🧠⏰♾️
0 · Reply
Alidrisi
Alidrisi Sep. 22 at 5:10 PM
$VANI Extremely
0 · Reply
ToniesPick
ToniesPick Sep. 19 at 7:42 PM
$VANI added a starter
0 · Reply
oneyedjacks
oneyedjacks Sep. 19 at 1:53 PM
$ALT should go buy $VANI and impant Pemvi
1 · Reply
Kkai14
Kkai14 Sep. 19 at 8:19 AM
$VANI
0 · Reply
smartkarma
smartkarma Sep. 19 at 2:34 AM
$VANI | Vivani Medical Prepares Spin-Off of Cortigent: Neuromodulation Gets Its Own Spotlight "​Vivani Medical sets record date for spin-off of Cortigent Inc., offering investors exposure to neuromodulation and drug implants with potential for valuation uplift." - Garvit Bhandari (GSBR Research) Read more: https://www.smartkarma.com/insights/vivani-medical-prepares-spin-off-of-cortigent-neuromodulation-gets-its-own-spotlight
0 · Reply
StockScanners
StockScanners Sep. 19 at 1:49 AM
$VANI reach 1.74
0 · Reply
BC322032
BC322032 Sep. 18 at 12:27 PM
$VANI THIS! This is how people become ultra rich - They buy with inside knowledge! Our turn. Adding!
0 · Reply